Nephrotic syndrome classification: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (7 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Nephrotic syndrome}} | {{Nephrotic syndrome}} | ||
{{CMG}} {{APM}}; {{AE}} {{OO}} [[User:YazanDaaboul|Yazan Daaboul]], | {{CMG}}, {{APM}}; {{AE}} {{OO}}, [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]] | ||
[[User:Sergekorjian|Serge Korjian]] | |||
==Overview== | ==Overview== | ||
Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology. Primary (idiopathic) nephrotic syndrome is defined as nephrotic syndrome due to a primary [[glomerular]] disease. | Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology. Primary (idiopathic) nephrotic syndrome is defined as nephrotic syndrome due to a primary [[glomerular]] disease. The secondary nephrotic syndrome is defined as nephrotic syndrome due to a primary etiology other than glomerular disorders, such as [[infection]]s, [[malignancies]], systemic conditions, and [[medication]]s. | ||
==Classification== | ==Classification== | ||
| Line 17: | Line 15: | ||
{{familytree/end}} | {{familytree/end}} | ||
</center> | </center> | ||
* Below table lists different types of nephrotic syndromes:<ref name="pmid10793022">{{cite journal |vauthors=Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA, Germain MJ |title=Changing incidence of glomerular diseases in adults |journal=Am. J. Kidney Dis. |volume=35 |issue=5 |pages=878–83 |date=May 2000 |pmid=10793022 |doi= |url=}}</ref><ref name="pmid15327377">{{cite journal |vauthors=Heaf J |title=The Danish Renal Biopsy Register |journal=Kidney Int. |volume=66 |issue=3 |pages=895–7 |date=September 2004 |pmid=15327377 |doi=10.1111/j.1523-1755.2004.00832.x |url=}}</ref><ref name=" | * Below table lists different types of nephrotic syndromes:<ref name="pmid10793022">{{cite journal |vauthors=Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA, Germain MJ |title=Changing incidence of glomerular diseases in adults |journal=Am. J. Kidney Dis. |volume=35 |issue=5 |pages=878–83 |date=May 2000 |pmid=10793022 |doi= |url=}}</ref><ref name="pmid15327377">{{cite journal |vauthors=Heaf J |title=The Danish Renal Biopsy Register |journal=Kidney Int. |volume=66 |issue=3 |pages=895–7 |date=September 2004 |pmid=15327377 |doi=10.1111/j.1523-1755.2004.00832.x |url=}}</ref><ref name="pmid28392820">{{cite journal |vauthors=Ha TS |title=Genetics of hereditary nephrotic syndrome: a clinical review |journal=Korean J Pediatr |volume=60 |issue=3 |pages=55–63 |date=March 2017 |pmid=28392820 |pmc=5383633 |doi=10.3345/kjp.2017.60.3.55 |url=}}</ref> | ||
{| | {| | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Different types of nephrotic syndromes | |||
! colspan="2" |Disease name | ! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name | ||
|- | |- | ||
! rowspan="6" align="center" style="background:#DCDCDC;" + |Podocytopathies | |||
| rowspan="2" |Primary | | rowspan="2" align="left" style="background:#F5F5F5;" + |Primary | ||
|[[Minimal change disease]] | | align="left" style="background:#F5F5F5;" + |[[Minimal change disease]] | ||
|- | |- | ||
|[[Focal segmental glomerulosclerosis]] ([[Focal segmental glomerulosclerosis|FSGS]]) | | align="left" style="background:#F5F5F5;" + |[[Focal segmental glomerulosclerosis]] ([[Focal segmental glomerulosclerosis|FSGS]]) | ||
|- | |- | ||
| rowspan="4" |Secondary | | rowspan="4" align="left" style="background:#F5F5F5;" + |Secondary | ||
|Infection such as: | | align="left" style="background:#F5F5F5;" + |Infection such as: | ||
* [[Human Immunodeficiency Virus (HIV)|HIV]] | * [[Human Immunodeficiency Virus (HIV)|HIV]] | ||
|- | |- | ||
|Drugs/toxins such as: | | align="left" style="background:#F5F5F5;" + |Drugs/toxins such as: | ||
* [[Non-steroidal anti-inflammatory drug|NSAIDs]] | * [[Non-steroidal anti-inflammatory drug|NSAIDs]] | ||
* Interferon | * Interferon | ||
| Line 40: | Line 38: | ||
* Envenomation | * Envenomation | ||
|- | |- | ||
|Malignancies such as: | | align="left" style="background:#F5F5F5;" + |Malignancies such as: | ||
* [[Hodgkin's lymphoma|Hodgkin lymphoma]] | * [[Hodgkin's lymphoma|Hodgkin lymphoma]] | ||
* [[Thymoma]] | * [[Thymoma]] | ||
|- | |- | ||
|Genetic disorders such as: | | align="left" style="background:#F5F5F5;" + |Genetic disorders such as: | ||
* [[Nephrin]] mutations | * [[Nephrin]] mutations | ||
* [[Podocin]] gene mutations | * [[Podocin]] gene mutations | ||
|- | |- | ||
! rowspan="2" align="center" style="background:#DCDCDC;" + |[[Membranous glomerulonephritis]] | |||
|Primary | | align="left" style="background:#F5F5F5;" + |Primary | ||
|[[Membranous nephritis|Membranous nephropathy]] | | align="left" style="background:#F5F5F5;" + |[[Membranous nephritis|Membranous nephropathy]] | ||
|- | |- | ||
|Secondary | | align="left" style="background:#F5F5F5;" + |Secondary | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* [[Drugs]] | * [[Drugs]] | ||
* [[Toxin|Toxins]] | * [[Toxin|Toxins]] | ||
* [[Cancer|Malignancies]] | * [[Cancer|Malignancies]] | ||
|- | |- | ||
|[[Membranoproliferative glomerulonephritis]] | ! align="center" style="background:#DCDCDC;" + |[[Membranoproliferative glomerulonephritis]] | ||
|Secondary | | align="left" style="background:#F5F5F5;" + |Secondary | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Autoimmune disorders such as: | * Autoimmune disorders such as: | ||
** [[SLE]] | ** [[SLE]] | ||
| Line 71: | Line 69: | ||
* [[Thrombotic microangiopathy]] | * [[Thrombotic microangiopathy]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Hereditary Nephropathy | |||
| colspan="2" | | | colspan="2" align="left" style="background:#F5F5F5;" + | | ||
* [[Alport syndrome]] | * [[Alport syndrome]] | ||
* [[IgA nephropathy]] | * [[IgA nephropathy]] | ||
* C1q nephropathy | * C1q nephropathy | ||
|- | |- | ||
|Glomerular deposition diseases | ! align="center" style="background:#DCDCDC;" + |[[Glomerular deposition disease|Glomerular deposition diseases]] | ||
| colspan="2" | | | colspan="2" align="left" style="background:#F5F5F5;" + | | ||
* [[Diabetes mellitus]] | * [[Diabetes mellitus]] | ||
* [[Amyloidosis]] | * [[Amyloidosis]] | ||
| Line 84: | Line 82: | ||
* Nodular glomeruloneohritis associated with heavy [[smoking]] | * Nodular glomeruloneohritis associated with heavy [[smoking]] | ||
|- | |- | ||
| | ! align="center" style="background:#DCDCDC;" + |Others | ||
| colspan="2" | | | colspan="2" align="left" style="background:#F5F5F5;" + | | ||
* [[Fabry's disease|Fabry disease]] | * [[Fabry's disease|Fabry disease]] | ||
* [[Nail-patella syndrome]] | * [[Nail-patella syndrome]] | ||
| Line 93: | Line 91: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | |||
[[Category:Medicine]] | |||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category: | [[Category:Urology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category: | [[Category:Emergency medicine]] | ||
Latest revision as of 22:57, 29 July 2020
|
Nephrotic Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Nephrotic syndrome classification On the Web |
|
American Roentgen Ray Society Images of Nephrotic syndrome classification |
|
Risk calculators and risk factors for Nephrotic syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3], Yazan Daaboul, Serge Korjian
Overview
Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology. Primary (idiopathic) nephrotic syndrome is defined as nephrotic syndrome due to a primary glomerular disease. The secondary nephrotic syndrome is defined as nephrotic syndrome due to a primary etiology other than glomerular disorders, such as infections, malignancies, systemic conditions, and medications.
Classification
- Nephrotic syndrome can be classified into primary or secondary depending on the underlying etiology.[1]
| Nephrotic syndrome | |||||||||||||||||||
| Primary | Secondary | ||||||||||||||||||
| Different types of nephrotic syndromes | Disease name | |
|---|---|---|
| Podocytopathies | Primary | Minimal change disease |
| Focal segmental glomerulosclerosis (FSGS) | ||
| Secondary | Infection such as: | |
Drugs/toxins such as:
| ||
| Malignancies such as: | ||
| Genetic disorders such as: | ||
| Membranous glomerulonephritis | Primary | Membranous nephropathy |
| Secondary | ||
| Membranoproliferative glomerulonephritis | Secondary |
|
| Hereditary Nephropathy |
| |
| Glomerular deposition diseases |
| |
| Others | ||
References
- ↑ Kodner C (2009). "Nephrotic syndrome in adults: diagnosis and management". Am Fam Physician. 80 (10): 1129–34. PMID 19904897.
- ↑ Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA, Germain MJ (May 2000). "Changing incidence of glomerular diseases in adults". Am. J. Kidney Dis. 35 (5): 878–83. PMID 10793022.
- ↑ Heaf J (September 2004). "The Danish Renal Biopsy Register". Kidney Int. 66 (3): 895–7. doi:10.1111/j.1523-1755.2004.00832.x. PMID 15327377.
- ↑ Ha TS (March 2017). "Genetics of hereditary nephrotic syndrome: a clinical review". Korean J Pediatr. 60 (3): 55–63. doi:10.3345/kjp.2017.60.3.55. PMC 5383633. PMID 28392820.